source
- Global regulators must align on new approach methodologies to give sponsors certaintyNew approach methodologies, or NAMs, are being promoted as ways to reduce reliance on animal testing in drug development. They promise faster, more humane studies while still providing safety data.…
- Pharma firms ask Trump admin to safeguard China partnerships as EU pushes for quicker trials and higher spendingPharma companies in the United States are urging the Trump administration to take steps that would protect their existing and future business arrangements with Chinese partners. At the same time,…